Clinical Trial Update: Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the combination of docetaxel with radiation therapy in patients with stage II or III cancer of the larynx or hypopharynx.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Cancer
• Laryngeal Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Aichi Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED